Mint Tower Capital Management B.V. Gilead Sciences, Inc. Call Options Transaction History

Mint Tower Capital Management B.V.

$318 Million
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $1.56 Million - $2.24 Million	-25,000 Reduced 50.0%	25,000 $2.15 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $720,434 - $822,921	12,100 Added 31.93%	50,000 $3.09 Million
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $582,972 - $656,601	-10,100 Reduced 21.04%	37,900 $2.34 Million
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $2.66 Million - $3.34 Million	46,000 Added 2300.0%	48,000 $2.85 Million
Q4 2021 Feb 04, 2022	BUY	$64.88 - $73.64 $129,759 - $147,280	2,000 New	2,000 $145,000
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $6.46 Million - $8.27 Million	-103,100 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $1.42 Million - $1.56 Million	-23,000 Reduced 18.24%	103,100 $6.7 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $1.27 Million - $1.4 Million	20,300 Added 19.19%	126,100 $7.99 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $1.84 Million - $2.06 Million	-29,700 Reduced 21.92%	105,800 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $8.47 Million - $9.49 Million	135,427 Added 185516.44%	135,500 $8.81 Million
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $4,419 - $5,767	73 New	73 $4,000
Q3 2018 Nov 06, 2018	SELL	$71.28 - $78.92 $6.42 Million - $7.1 Million	-90,000 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $1.62 Million - $1.89 Million	-25,000 Reduced 21.74%	90,000 $6.38 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $8.36 Million - $10.2 Million	114,825 Added 65614.29%	115,000 $8.67 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $12,451 - $14,616	175	175 $1.25 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.8 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.88 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.55 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.41 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mint Tower Capital Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mint Tower Capital Management B.V. with notifications on news.

Account